Zivi, A., Hong, D. S., Patel, M. R., Thomas, J. S., Bruce, J. Y., Goel, S., Hanna, G. J., Medioni, J., Salvagni, S., Ulahannan, S. V., Hendifar, A., Laux, D. E., Alonso, G., Vozy, A., Yarza, R., Tran, T. A., Kuan, J., Balsara, B., Seraj, J., Gregorc, V. (2026). Farnesyl transferase inhibitor (FTI) darlifarnib (KO-2806) in combination with adagrasib in KRAS G12C mutated (mut) advanced solid tumors: Preliminary results from the FIT-001 phase 1 first-in-human trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3078